NDT Plus Advance Access originally published online on November 21, 2008
NDT Plus 2009 2(1):72-75; doi:10.1093/ndtplus/sfn171
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Fluindione-induced immuno-allergic interstitial nephritis
1 Department of Nephrology
2 Department of Pathology, Pitie-Salpetiere Hospital
3 Department of Nephrology, AURA, Paris, France
Correspondence: Correspondence and offprint requests to: Hassane Izzedine, Department of Nephrology, La Pitié-Salpêtrière Hospital, 47-80 Boulevard de lHôpital, Assistance Publique-Hôpitaux de Paris, Pierre et Marie Curie University, 75013 Paris, France. Tel: +33142177225; Fax: +33142177232; E-mail: hassan.izzedine@psl.aphp.fr
Key Words: acute interstitial nephritis corticosteroids fluindione
Received for publication July 18, 2008. Accepted for publication October 21, 2008.
| The first 10% of the full text of this article appears below. |
Drug-induced acute interstitial nephritis (AIN) is an established cause of acute kidney injury (AKI). Antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) are the most frequent offending drugs [1]. Only a few vitamin K antagonist-induced AIN cases have been reported. Some publications describe AIN associated with fluindione (Previscan®), an anticoagulant of the antivitamin K family, derived from indanedione, exclusively marketed in France. We present an additional case of AIN secondary to fluindione and review the
| Teaching point |
|---|